Zura Bio Limited Fiscal Q1 2026 Earnings | StockRay
StockRay
Z
Zura Bio Limited
Q1 2026 earnings
Quarter
Jan – Mar
Released
May 7, 2026
(ET)
EPS
This quarter
-$0.22
Analyst estimate
-$0.17
▼ -26.6%
Year ago (Mar '25)
-$0.19
▼ -15.8%
Related to this earnings
Zura Bio Exceeds Enrollment Target in Both Hidradenitis Suppurativa (HS) & Systemic Sclerosis (SSc) Phase 2 Studies and Expands Tibulizumab Program
Jun 29
Back to stock page
